- Home
- TVGN vs INGN Comparison
TVGN vs INGN Comparison
Compare TVGN & INGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TVGN
- INGN
- Stock Information
- Founded
- TVGN 2020
- INGN 2001
- Country
- TVGN United States
- INGN United States
- Employees
- TVGN N/A
- INGN N/A
- Industry
- TVGN Blank Checks
- INGN Industrial Specialties
- Sector
- TVGN Finance
- INGN Health Care
- Exchange
- TVGN Nasdaq
- INGN Nasdaq
- Market Cap
- TVGN 193.1M
- INGN 182.8M
- IPO Year
- TVGN N/A
- INGN 2014
- Fundamental
- Price
- TVGN $1.06
- INGN $6.80
- Analyst Decision
- TVGN Strong Buy
- INGN Strong Buy
- Analyst Count
- TVGN 1
- INGN 3
- Target Price
- TVGN $10.00
- INGN $11.00
- AVG Volume (30 Days)
- TVGN 645.6K
- INGN 175.6K
- Earning Date
- TVGN 08-13-2025
- INGN 08-07-2025
- Dividend Yield
- TVGN N/A
- INGN N/A
- EPS Growth
- TVGN N/A
- INGN N/A
- EPS
- TVGN N/A
- INGN N/A
- Revenue
- TVGN N/A
- INGN $339,960,000.00
- Revenue This Year
- TVGN N/A
- INGN $7.47
- Revenue Next Year
- TVGN N/A
- INGN $6.22
- P/E Ratio
- TVGN N/A
- INGN N/A
- Revenue Growth
- TVGN N/A
- INGN 5.73
- 52 Week Low
- TVGN $0.26
- INGN $5.70
- 52 Week High
- TVGN $3.09
- INGN $13.33
- Technical
- Relative Strength Index (RSI)
- TVGN 36.03
- INGN 50.80
- Support Level
- TVGN $1.18
- INGN $6.27
- Resistance Level
- TVGN $1.42
- INGN $6.73
- Average True Range (ATR)
- TVGN 0.07
- INGN 0.27
- MACD
- TVGN -0.02
- INGN -0.03
- Stochastic Oscillator
- TVGN 5.26
- INGN 39.55
About TVGN Tevogen Bio Holdings Inc. Common Stock
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.
About INGN Inogen Inc
Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. Internationally, It sells its products through distributors large gas companies, and home oxygen providers. It generates the majority of its revenue in the United States.